Literature DB >> 23756458

Mortality due to viral hepatitis in the Global Burden of Disease Study 2010: new evidence of an urgent global public health priority demanding action.

Benjamin C Cowie1, Kylie S Carville, Jennifer H MacLachlan.   

Abstract

The recently published Global Burden of Disease Study 2010 (GBD 2010) contains accurate, contemporary estimates of human morbidity and mortality, with substantial changes in the patterns of illness observed over the last two decades. One of the most significant alterations to these estimates has been the recognition that viral hepatitis is a leading cause of human mortality, with an estimated 1.29 million deaths worldwide in 2010. The global community must act to address emerging health priorities identified by GBD 2010, including the need to provide treatment and care to people living with viral hepatitis, especially in resource-poor settings.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23756458     DOI: 10.3851/IMP2654

Source DB:  PubMed          Journal:  Antivir Ther        ISSN: 1359-6535


  11 in total

Review 1.  Hepatitis B virus epidemiology.

Authors:  Jennifer H MacLachlan; Benjamin C Cowie
Journal:  Cold Spring Harb Perspect Med       Date:  2015-05-01       Impact factor: 6.915

2.  Age-related immune clearance of hepatitis B virus infection requires the establishment of gut microbiota.

Authors:  Han-Hsuan Chou; Wei-Hung Chien; Li-Ling Wu; Chi-Hung Cheng; Chen-Han Chung; Jau-Haw Horng; Yen-Hsuan Ni; Hong-Tai Tseng; Dafei Wu; Xuemei Lu; Hurng-Yi Wang; Pei-Jer Chen; Ding-Shinn Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

Review 3.  Novel Indications for Fecal Microbial Transplantation: Update and Review of the Literature.

Authors:  Nathaniel Aviv Cohen; Nitsan Maharshak
Journal:  Dig Dis Sci       Date:  2017-03-17       Impact factor: 3.199

4.  New insights into the evolutionary rate of hepatitis B virus at different biological scales.

Authors:  You-Yu Lin; Chieh Liu; Wei-Hung Chien; Li-Ling Wu; Yong Tao; Dafei Wu; Xuemei Lu; Chia-Hung Hsieh; Pei-Jer Chen; Hurng-Yi Wang; Jia-Horng Kao; Ding-Shinn Chen
Journal:  J Virol       Date:  2015-01-14       Impact factor: 5.103

5.  Prevalence and predictors of HCV among a cohort of opioid treatment patients in Dar es Salaam, Tanzania.

Authors:  Barrot H Lambdin; Jennifer Lorvick; Jessie K Mbwambo; John Rwegasha; Saria Hassan; Paula Lum; Alex H Kral
Journal:  Int J Drug Policy       Date:  2017-06-17

6.  High-resolution crystal structure of a hepatitis B virus replication inhibitor bound to the viral core protein.

Authors:  Klaus Klumpp; Angela M Lam; Christine Lukacs; Robert Vogel; Suping Ren; Christine Espiritu; Ruth Baydo; Kateri Atkins; Jan Abendroth; Guochun Liao; Andrey Efimov; George Hartman; Osvaldo A Flores
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-23       Impact factor: 11.205

7.  Aiming at the Global Elimination of Viral Hepatitis: Challenges Along the Care Continuum.

Authors:  Alastair Heffernan; Ella Barber; Nicola A Cook; Asmaa I Gomaa; Yolande X Harley; Christopher R Jones; Aaron G Lim; Zameer Mohamed; Shevanthi Nayagam; Gibril Ndow; Rajiv Shah; Mark W Sonderup; C Wendy Spearman; Imam Waked; Robert J Wilkinson; Simon D Taylor-Robinson
Journal:  Open Forum Infect Dis       Date:  2017-11-17       Impact factor: 3.835

8.  Predictors for Early Identification of Hepatitis C Virus Infection.

Authors:  Mei-Hua Tsai; Kuei-Hsiang Lin; Kuan-Tsou Lin; Chi-Ming Hung; Hung-Shiang Cheng; Yu-Chang Tyan; Hui-Wen Huang; Bintou Sanno-Duanda; Ming-Hui Yang; Shyng-Shiou Yuan; Pei-Yu Chu
Journal:  Biomed Res Int       Date:  2015-08-27       Impact factor: 3.411

9.  Chronic viral hepatitis: policy, regulation, and strategies for its control and elimination in Ethiopia.

Authors:  Fassil Shiferaw; Mekitew Letebo; Abate Bane
Journal:  BMC Public Health       Date:  2016-08-11       Impact factor: 3.295

10.  Beyond the diagnosis: a qualitative exploration of the experiences of persons with hepatitis B in the Accra Metropolis, Ghana.

Authors:  Charles Ampong Adjei; Florence Naab; Ernestina S Donkor
Journal:  BMJ Open       Date:  2017-11-03       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.